Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Here, we address the question of why the influenza A virus hemagglutinin (HA) does not escape immunity by hyperglycosylation. Uniquely among dozens of monoclonal antibodies specific for A/Puerto Rico/8/34, escape from H28-A2 neutralization requires substitutions introducing N-linked glycosylation at residue 131 or 144 in the globular domain. This escape decreases viral binding to cellular receptors, which must be compensated for by additional substitutions in HA or neuraminidase that enable viral replication. Sequence analysis of circulating H1 influenza viruses confirms the in vivo relevance of our findings: natural occurrence of glycosylation at residue 131 is always accompanied by a compensatory mutation known to increase HA receptor avidity. In vaccinated mice challenged with WT vs. H28-A2 escape mutants, the selective advantage conferred by glycan-mediated global reduction in antigenicity is trumped by the costs of diminished receptor avidity. These findings show that, although N-linked glycosylation can broadly diminish HA antigenicity, fitness costs restrict its deployment in immune evasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This explains a common immune escape strategy of enveloped viruses, whose surface glycoproteins tend to be very heavily glycosylated (592 -593).”
From Biological roles of glycans (2017) · cites this paper as [593]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However larger glycans typically disrupt peptide loading and/or T-cell receptor recognition, and often eliminate it altogether.”
From Biological roles of glycans (2017) · cites this paper as [593]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,415 · cited 1×
“HA is a homotrimer that attaches virus to terminal sialic acid residues on target cells to initiate the infectious cycle (1).”
BackgroundAntibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326 · cited 1×
“Binding to H3 HA, however, is likely blocked by the presence of an N-linked glycan absent on H1/H2/H5 HAs (22, 23), raising the possibility of glycan-based escape from immunization strategies aimed at inducing stem-reactive mAbs.”
BackgroundThe antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,034 · cited 3×
“Sequencing RNA of escape mutants resistant to neutralization by individual monoclonal Abs (mAbs) revealed that mutants typically possess a single nucleotide change generating an amino acid substitution in the globular domain (3).”
BackgroundSelf-citationThrosby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737 · cited 1×
“Binding to H3 HA, however, is likely blocked by the presence of an N-linked glycan absent on H1/H2/H5 HAs (22, 23), raising the possibility of glycan-based escape from immunization strategies aimed at inducing stem-reactive mAbs.”
BackgroundHemagglutinin receptor binding avidity drives influenza A virus antigenic drift
Hensley, S. E., Das, S. R., Bailey, A. L., Schmidt, L. M., Hickman, H. D., Jayaraman, A., Viswanathan, K., Raman, R., Sasisekharan, R., Bennink, J. R., et al. (2009) · Science · doi:10.1126/science.1178258 · Cited by 484 · cited 5×
“Indeed, we reported that the compensatory amino acids observed in the OV variants increase HA receptor avidity (15, 16).”
BackgroundMethodResultSelf-citationAntigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies
Gerhard, W., Yewdell, J., Frankel, M. E., & Webster, R. (1981) · Nature · doi:10.1038/290713a0 · Cited by 460 · cited 3×
“By contrast, residue 131 is likely glycosylated in a number of strains, including A/Melbourne/35, which shows greatly reduced binding of H28-A2 (9).”
BackgroundMethodSelf-citationAntigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule
YEWDELL, J. W., WEBSTER, R. G., & GERHARD, W. U. (1979) · Nature · doi:10.1038/279246a0 · Cited by 189 · cited 4×
“Variants frequencies were determined either as described (5) or using a modified protocol with MDCK cells.”
BackgroundMethodSelf-citationAntigenic Characterization of Viruses by Monoclonal Antibodies
Yewdell, J. W., & Gerhard, W. (1981) · Annual Review of Microbiology · doi:10.1146/annurev.mi.35.100181.001153 · Cited by 139 · cited 1×
“This method of epitope mapping, although indirect, is much more rapid and robust than other methods, and it is still capable of providing a reasonable physical definition of the relevant epitope (4).”
MethodSelf-citationStructural basis of influenza virus neutralization
Han, T. K., & Marasco, W. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05829.x · Cited by 131 · cited 1×
“This discussion is relevant to the recent description of mAbs that bind highly conserved epitopes in the stem region of HA, which allows them to neutralize nearly all isolates within the H1 subtype and even between H1, H2, and H5 subtypes (21).”
BackgroundStaudt, L. M., & Gerhard, W. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.157.2.687 · Cited by 125 · cited 1×
“Three other mAbs characterized in detail from the same fusion are specific for the Sb site, which is likely immunodominant in mice (16, 17).”
Background
Research works printed but not linked: 6
- Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) Cell. 1982;31:417–427. doi: 10.1016/0092-8674(82)90135-0. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1038/279246a0 · DOI · Paper page
- JW Yewdell The study of influenza virus antigens by means of monoclonal hybridoma antibodies. (University of Pennsylvania Philadelphia PhD thesis. (1981).
- Hensley SE, et al. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One. 2011;6:e15190. doi: 10.1371/journal.pone.0015190. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- Yewdell JW, Caton AJ, Gerhard W. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol. 1986;57:623–628. doi: 10.1128/jvi.57.2.623-628.1986. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
- Hensley SE, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science. 2009;326:734–736. doi: 10.1126/science.1178258. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“escape strategy of enveloped viruses, whose surface glycoproteins tend to be very heavily glycosylated (592, 593).”
BackgroundZost, S. J., Parkhouse, K., Gumina, M. E., Kim, K., Diaz Perez, S., Wilson, P. C., Treanor, J. J., Sant, A. J., Cobey, S., & Hensley, S. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712377114 · Cited by 563
Self-citationExploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
“3) and plays a vital role in viral entry by binding to host receptors via the receptor binding site (RBS) located on HA1.”
Background
Metadata
- Authors
- Das, S. R., Hensley, S. E., David, A., Schmidt, L., Gibbs, J. S., Puigbò, P., Ince, W. L., Bennink, J. R., & Yewdell, J. W.
- Affiliations
- National Institutes of Health (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-11-21
- Volume
- 108
- Issue
- 51
- Pages
- E1417-22
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3251056
- OpenAlex
- W2017618875
- Cited by
- 143
- References
- 22
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 10 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 14 · 2013: 21 · 2012: 6
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (U19AI057266)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- influenza A virus, hemagglutinin, N-glycosylation, hyperglycosylation, immune evasion, neutralizing antibodies, compensatory mutations, viral fitness cost, neuraminidase, antigenic variation
- MeSH terms
- Animals, Antigens, Dogs, Glycosylation, Hemagglutinins, Humans, Immune System, Mice, Inbred BALB C, Mice, Inbred C57BL, Models, Molecular, Molecular Conformation, Mutation, Influenza A virus, Virus Replication, Epitope Mapping, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. https://app.cochat.ai/papers/10.1073/pnas.1108754108
- The paper
- Das, S. R., Hensley, S. E., David, A., Schmidt, L., Gibbs, J. S., Puigbò, P., Ince, W. L., Bennink, J. R., & Yewdell, J. W. (2011). Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1108754108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.